Skip to content

Advanced planning of DIEP flap patients

Advanced planning of DIEP flap patients - Advanced planning of DIEP flap patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42586
Enrollment
76
Registered
2015-10-13
Start date
2015-11-02
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Predictabiliy of bloodvessel locations in breast reconstructions

Interventions

The control group receives standard care
perforator location planning through US Doppler. The projection group receives additional planning based on CT data and the perforator locations are displayed on the abdomen

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age 18 years of older. Patients scheduled for direct, delayed, unilateral or bilateral deep inferior epigastric perforator flap breast reconstruction surgery. Patients willing to participate (written informed consent).

Exclusion criteria

Exclusion criteria: Patients with intolerance / hypersensitivity to Iomeron© (iomeprol). Patients who undergo a deep inferior epigastric perforator flap with additional lymph node transfer.

Design outcomes

Primary

MeasureTime frame
The proportion of correctly and incorrectly identified perforators found with both techniques, compared to intraoperative results in each harvested flap (true positives). The total harvest time for each flap.

Secondary

MeasureTime frame
Ratio of perforators correctly predicted used for transplantation Task load of the surgeon with different planning techniques Intra- and post-operative morbidity including fat necrosis, partial or total flap loss, arterial thrombosis, venous congestion and perforator destruction between both groups. Differences in total procedure time.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)